Prof. Stephen Dalton recently joined School of Biomedical Sciences, CUHK as Professor and has been conferred the title “Global STEM Scholar” under the Global STEM Professorship Scheme launched by the Government of Hong Kong Special Administrative Region, with effect from January 2022.

Prof. Dalton received his Ph.D. in Biochemistry and Molecular Biology from the University of Adelaide, Australia, followed by post-doctoral research at the Imperial Cancer Research Fund in London, U.K. Afterwards, he joined the Roche Institute of Molecular Biology in Nutley, New Jersey, followed by an academic position in University of Adelaide, Australia.  Prior to joining CUHK, Prof. Dalton was a Professor and Endowed Chair in the Department of Molecular Cell Biology, and Founding Director of the Center for Molecular Medicine, University of Georgia, U.S.A. 

This newly launched Global STEM Professorship Scheme aims at helping universities in Hong Kong to recruit internationally renowned Innovation and Technology (I&T) scholars and their teams to Hong Kong, hence scaling new heights in I&T teaching and research activities of local universities.  Prof. Dalton now has initiated a program focusing on therapeutic development for type 2 diabetes using technology developed in his laboratory and will continue his work in adult adipose-derived stem cells and pluripotent stem cell biology.

Prof. Stephen Dalton